Effects of propranolol on coronary vasculature and cardiac performance in dogs with fixed and dynamic coronary stenosis.
The coronary hemodynamic effects of propranolol (0.1 mg/kg, i.v.) were examined in anesthetized dogs with flow-limiting dynamic and fixed coronary stenosis of the left circumflex coronary artery. During fixed coronary stenosis created by external application of an occluder device, propranolol significantly decreased coronary blood flow (CBF) by 6.8 +/- 2.7% (mean +/- SEM, p less than 0.05) and increased mean distal coronary pressure (DCP) by 7 +/- 2.1 mmHg (p less than 0.05). This resulted in a decrease in stenosis resistance (SR) by 26 +/- 3.1% (p less than 0.01) due to oxygen demand reduction. By contrast, during dynamic coronary stenosis produced by an intraluminal microballoon occluder, propranolol decreased CBF by 68 +/- 3.4% (p less than 0.01) and mean DCP by 36 +/- 4.2 mmHg (p less than 0.01), resulting in an increase in SR by 694 +/- 109% (p less than 0.01). This increase in SR was attenuated by pretreatment with an alpha-adrenergic receptor antagonist phentolamine (0.5 mg/kg, i.v.), or by holding heart rate constant at the pretreatment level. These results suggest that propranolol ameliorated the severity of stenosis during fixed coronary stenosis and exacerbated the severity during dynamic coronary stenosis. This increase in SR appears to be related to vasoconstriction of the large stenosed coronary artery, mediated both by alpha-adrenergic receptors in the coronary artery and by myocardial oxygen demand reduction.
Kashiki
M
M
First Department of Medicine, Kobe University School of Medicine, Japan.
Yokoyama
M
M
Fukuzaki
H
H
D000818:Animals; D003250:Constriction; D003326:Coronary Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy*; D003331:Coronary Vessels / Q000187:drug effects*; D004285:Dogs; D006439:Hemodynamics / Q000187:drug effects*; D011433:Propranolol / Q000627:therapeutic use*
D011433:Propranolol